epicatechin gallate has been researched along with Cancer of Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwi, D; Banerjee, P; Fried, A; Hussaini, R; Mukherjee, S; Pan, Q; Piao, L; Sampat, S; White, R | 1 |
| Baek, SJ; Choi, EC; Lee, SH; Lim, YC; Song, MH; Yamaguchi, K; Yoon, JH | 1 |
2 other study(ies) available for epicatechin gallate and Cancer of Head
| Article | Year |
|---|---|
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Catechin; Curcumin; Female; Head and Neck Neoplasms; Humans; Killer Cells, Natural; Lung Neoplasms; Macrophages; Mice; Mice, Inbred C57BL; Mice, Nude; Papillomaviridae; Papillomavirus Infections; Resveratrol; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Growth inhibition and apoptosis by (-)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Flavonoids; Flow Cytometry; Growth Differentiation Factor 15; Growth Inhibitors; Head and Neck Neoplasms; Humans; Neoplasm Proteins; Phenols; Polyphenols | 2006 |